IP Library › Granted Patent US 7,341,867
Granted Patent B2
US 7,341,867 · App. 10/628,066 · Granted Mar 11, 2008

Human preprotachykinin gene promoter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,341,867
App. No.
10/628,066
Granted
Mar 11, 2008
Kind
B2
Abstract

Compositions and methods are provided for identifying novel therapeutic agents for the treatment of breast cancer, bone marrow metastasis, pain, arthritis, aggressive behavior, depression, and certain hematopoietic disorders. Disclosed are promoters and 3′ regulatory regions of genes whose expression differs in malignant cells as compared with non-malignant cells. These include PPT-I, NK-2 and SP-R.

Claims (3)

1. An isolated nucleic acid molecule comprising SEQ ID NO:1 or SEQ ID NO:14.

2. An expression vector comprising the nucleic acid molecule of claim 1 , operably linked to a heterologous gene that encodes a gene product.

3. An isolated host cell transformed with the vector of claim 2 .

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 033525/0369 →